Dec 16, 2023, 17:53
Guillaume Carpentier: Outstanding talk by Tapan Kadia on all oral tx with Dec-C plus Venetoclax in pts with AML ineligible for IC
Guillaume Carpentier, Assistant Professor in the Department of Medicine, Division of Hematology at Queen’s University, shared on X/Twitter:
“Outstanding talk by Tapan Kadia on all oral tx with Dec-C plus Venetoclax in pts with AML ineligible for IC!!! Dr Kadia is such an awesome mentor and role-model! Oral tx super relevant for QoL, especially in older pts or those who live far from cancer centres!”
Source: Guillaume Carpentier/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 14, 2024, 13:54
Dec 14, 2024, 13:50
Dec 14, 2024, 13:43
Dec 14, 2024, 13:39
Dec 14, 2024, 13:19